Cited by 496Lipoproteins and Cardiovascular HealthLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 122 of the 125 references it cites were found in a registry or an index.

Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

Civeira, Fernando·2004·Atherosclerosis

DOI 10.1016/j.atherosclerosis.2003.11.010

Open this paper in CoChat — free account

Abstract

Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism characterized by very high plasma concentrations of low density lipoprotein cholesterol (LDLc), tendon xanthomas and increased risk of premature coronary heart disease (CHD). FH is a public health problem throughout the world. There are 10,000,000 people with FH worldwide, mainly heterozygotes, and approximately 85% of males and 50% of females with FH will suffer a coronary event before 65 years old if appropriate preventive efforts are not implemented. Early identification of persons with FH and their relatives, and the early start of treatment are essential issues in the prevention of premature cardiovascular disease (CVD) and death in this population. However, guidelines for the general population formally exclude FH from their diagnostic and treatment recommendations. These guidelines have been elaborated by a group of international experts with the intention to answer the main questions about heterozygous FH (heFH) subjects that physicians worldwide face in the diagnosis and management of these patients.

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2003.11.010

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261

Flagged first, then by citations

Show all 125 references

3 of the 125 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Defesche J. Familial hypercholesterolemia. In: Betteridge J, editor. Lipids and vascular disease, vol. 6. London: Martin Dunitz; 2000. p. 65–76.
Mabuchi, 1989, Development of coronary heart disease in familial hypercholesterolemia, Circulation, 79, 225, 10.1161/01.CIR.79.2.225 · DOI

Sorted by citations

Items 101–200 of 496

Long-Term Follow-Up of Statin Treatment in a Cohort of Children with Familial Hypercholesterolemia
Carreau, V., Girardet, J.-P., & Bruckert, É. (2011) · Pediatric Drugs · doi:10.2165/11591650-000000000-00000 · Cited by 50
Semi-Supervised Learning of the Electronic Health Record for Phenotype StratificationPreprint
Beaulieu‐Jones, B. K., & Greene, C. S. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/039800 · Cited by 48
Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities
Caballero, P., Rodrigo Alonso, K., Rosado, P., Mata, N., Fernández‐Friera, L., Jiménez‐Borreguero, L. J., Badimón, L., & Mata, P. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.043 · Cited by 48
Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
Bogsrud, M. P., Langslet, G., Wium, C., Johansen, D., Svilaas, A., & Holven, K. B. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.11.009 · Cited by 48
Can Multiple Lifestyle Behaviours Be Improved in People with Familial Hypercholesterolemia? Results of a Parallel Randomised Controlled Trial
Broekhuizen, K., van Poppel, M. N. M., Koppes, L. L. J., Kindt, I., Brug, J., & van Mechelen, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050032 · Cited by 50
Familial Hypercholesterolemia and Lipoprotein Apheresis
Makino, H., Koezuka, R., Tamanaha, T., Ogura, M., Matsuki, K., Hosoda, K., & Harada‐Shiba, M. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17033 · Cited by 48
Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes
Rodrigo Alonso, K., Mata, P., Zambón, D., Mata, N., & Fuentes, F. J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.7 · Cited by 42
Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia
Goldmann, R., Tichý, L., Freiberger, T., Zapletalová, P., Letocha, O., Soška, V., Fajkus, J., & Fajkusová, L. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-115 · Cited by 43
World Heart Federation Cholesterol Roadmap
Murphy, A., Faria-Neto, J. R., Al-Rasadi, K., Blom, D., Catapano, A., Cuevas, A., Lopez-Jimenez, F., Perel, P., Santos, R., Sniderman, A., et al. (2017) · Global Heart · doi:10.1016/j.gheart.2017.03.002 · Cited by 43
Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)
Safarova, M. S., & Moriarty, P. M. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01113-2 · Cited by 42
Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins
Rallidis, L. S., Triantafyllis, A. S., Tsirebolos, G., Katsaras, D. N., Rallidi, M., Moutsatsou, P., & Lekakis, J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.023 · Cited by 42
Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry
AlHabib, K. F., Al‐Rasadi, K., Almigbal, T. H., Batais, M. A., Al-Zakwani, I. S., Al-Allaf, F. A., Al-Waili, K., Zadjali, F., AlGhamdi, M. A., Alnouri, F., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251560 · Cited by 42
Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background
Choumerianou, D. M., & Dedoussis, G. V. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.134 · Cited by 42
Computationally Driven Structure Optimization, Synthesis, and Biological Evaluation of Imidazole-Based Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibitors
Lammi, C., Sgrignani, J., Arnoldi, A., Lesma, G., Spatti, C., Silvani, A., & Grazioso, G. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00402 · Cited by 41
LDL-R promoting activity of peptides derived from human PCSK9 catalytic domain (153–421): Design, synthesis and biochemical evaluation
Alghamdi, R. H., O'Reilly, P., Lu, C., Gomes, J., Lagace, T. A., & Basak, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.022 · Cited by 41
Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia
Jarauta, E., Mateo‐Gállego, R., Gilabert, R., Plana, N., Junyent, M., de Groot, E., Cenarro, A., Masana, L., Ros, E., & Civeira, F. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.011 · Cited by 40
Self-citation
The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study
Meshkov, A. N., Ershova, A. I., Kiseleva, A. V., Shalnova, S. A., Drapkina, O. M., Boytsov, S. A., & on behalf of the FH-ESSE-RF Investigators (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060464 · Cited by 40
Análisis coste-efectividad de un programa de cribado genético en familiares directos de pacientes con hipercolesterolemia familiar en España
Oliva, J., López‐Bastida, J., Moreno, S. G., Mata, P., & Rodrigo Alonso, K. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70021-1 · Cited by 39
Visible aging signs as risk markers for ischemic heart disease: Epidemiology, pathogenesis and clinical implications
Christoffersen, M., & Tybjærg‐Hansen, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.11.002 · Cited by 39
ABCG5/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols
Lamíquiz-Moneo, I., Baila-Rueda, L., Bea, A. M., Mateo‐Gállego, R., Pérez‐Calahorra, S., Marco-Benedí, V., Martín‐Navarro, A., Ros, E., Cofán, M., Rodríguez-Rey, J. C., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.09.005 · Cited by 38
Self-citation
Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry
Brunham, L. R., Ruel, I. L., Khoury, É., Hegele, R. A., Couture, P., Bergeron, J., Baass, A. W., Dufour, R., Francis, G. A., Cermakova, L., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.05.040 · Cited by 40
Familial hypercholesterolemia: a challenge of diagnosis and therapy.
Sibley, C. T., & Stone, N. J. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.1.57 · Cited by 38
Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study
Sanin, V., Schmieder, R. S., Ates, S., Schlieben, L. D., Wiehler, J., Sun, R., Decker, M., Sander, M., Holdenrieder, S., Kohlmayer, F., et al. (2022) · European Journal of Public Health · doi:10.1093/eurpub/ckac007 · Cited by 37
Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: Results of a family and DNA-based screening
Campagna, F., Martino, F., Bifolco, M., Montali, A., Martino, E., Morrone, F., Antonini, R., Cantàfora, A., Verna, R., & Arca, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.015 · Cited by 37
Cost-Effectiveness Analysis of a Genetic Screening Program in the Close Relatives of Spanish Patients With Familial Hypercholesterolemia
Oliva, J., López‐Bastida, J., Moreno, S. G., Mata, P., & Rodrigo Alonso, K. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)71514-2 · Cited by 37
Partial ligation-induced carotid artery occlusion induces leukocyte recruitment and lipid accumulation—A shear stress model of atherosclerosis
Merino, H., Parthasarathy, S., & Singla, D. K. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1468-7 · Cited by 36
Different lipid profiles according to ethnicity in the Heart of Soweto study cohort of de novo presentations of heart disease : cardiovascular topics
Sliwa, K. S., Lyons, J. G., Carrington, M. J., Lecour, S., Marais, A. D., Raal, F. J., & Stewart, S. (2012) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2012-036 · Cited by 35
Lipid‐lowering therapy with PCSK 9‐inhibitors in the real‐world setting: Two‐year experience of a regional lipid clinic
Zafrir, B., & Jubran, A. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12439 · Cited by 37
Genetic Deletion of Low Density Lipoprotein Receptor Impairs Sterol-induced Mouse Macrophage ABCA1 Expression
Zhou, X., He, W. S., Huang, Z., Gotto, A. M., Hajjar, D. P., & Han, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706636200 · Cited by 35
Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children
Page, M. M., Bell, D. A., Hooper, A. J., Watts, G. F., & Burnett, J. R. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.004 · Cited by 35
Severe Periodontitis Is Associated With Diastolic Blood Pressure Elevation in Individuals With Heterozygous Familial Hypercholesterolemia: A Pilot Study
Vieira, C. L. Z., Cury, P. R., Miname, M. H., Martinez, L. R. C., Bortolotto, L. A., Giuliano, I. D. C. B., Santos, R. D., & Caramelli, B. (2010) · Journal of Periodontology · doi:10.1902/jop.2010.100496 · Cited by 35
No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with Familial Hypercholesterolemia compared to usual care: results of a randomised controlled trial
Broekhuizen, K., van Poppel, M. N. M., Koppes, L. L. J., Kindt, I., Brug, J., & van Mechelen, W. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-181 · Cited by 34
Increased Intestinal Cholesterol Absorption in Autosomal Dominant Hypercholesterolemia and No Mutations in the Low-Density Lipoprotein Receptor or Apolipoprotein B Genes
García-Otín, A. L., Cofán, M., Junyent, M., Recalde, D., Cenarro, A., Pocovı́, M., Ros, E., & Civeira, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2567 · Cited by 33
Self-citation
The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia
ten Kate, G. R., Neefjes, L. A., Dedic, A., Nieman, K., Langendonk, J. G., Galema-Boers, A. J., van Lennep, J. E. R., Moelker, A. D., Krestin, G. P., Sijbrands, E. J. G., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.016 · Cited by 33
Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia
Fuentes, F. J., López‐Miranda, J., García, A., Pérez‐Martínez, P., Moreno, J. A., Cofán, M., Caballero‐Villarraso, J., Paniagua, J. A., Ros, E., & Pérez‐Jiménez, F. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602731 · Cited by 33
A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial
Broekhuizen, K., van Poppel, M. N. M., Koppes, L. L. J., Brug, J., & van Mechelen, W. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-69 · Cited by 33
The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results
Al‐Rasadi, K., AlHabib, K. F., Al-Allaf, F. A., Al-Waili, K., Al-Zakwani, I. S., Al-Sarraf, A. J., Almahmeed, W. A., Al-Sayed, N., AlGhamdi, M. A., Batais, M. A., et al. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666181005125459 · Cited by 33
International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?
Pang, J., Lansberg, P. J., & Watts, G. F. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.34108 · Cited by 32
Predicting cardiovascular disease in familial hypercholesterolemia
Paquette, M., & Baass, A. W. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000519 · Cited by 33
Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study
Negele, L., Schneider, B., Ristl, R., Stulnig, T. M., Willfort‐Ehringer, A., Helk, O., & Widhalm, K. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.234 · Cited by 32
Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia
Lamíquiz-Moneo, I., Restrepo-Córdoba, M. A., Mateo‐Gállego, R., Bea, A. M., Alberiche-Ruano, M. P., García‐Pavía, P., Cenarro, A., Martín, C., Civeira, F., & Sánchez-Hernández, R. M. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.025 · Cited by 33
Self-citation
PCSK9 inhibitors in clinical practice: Novel directions and new experiences
Rallidis, L. S., Skoumas, I., Liberopoulos, E. N., Vlachopoulos, C. V., Kiouri, E., Koutagiar, I. P., Anastasiou, G., Kosmas, N., Elisaf, M., Tousoulis, D., et al. (2019) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2019.10.003 · Cited by 31
Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology
Porras, A. M., Shanmuganayagam, D., Meudt, J. J., Krueger, C. G., Hacker, T. A., Rahko, P. S., Reed, J. D., & Masters, K. S. B. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002254 · Cited by 32
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum
Rynkiewicz, A., Cybulska, B., Banach, M., Filipiak, K. J., Guzik, T. J., Idzior−Waluś, B., Imiela, J., Jankowski, P., Kłosiewicz−Latoszek, L., Limon, J., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.01.005 · Cited by 31
Future issues, public policy, and public awareness of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Goldberg, A. C., Robinson, J. G., Cromwell, W. C., Ross, J. L., & Ziajka, P. E. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.04.002 · Cited by 31
ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage
Ramírez, C., Sierra, S., Tercero, I., Vázquez, J. A., Pineda, A., Manrique, T., & Burgos, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022712 · Cited by 31
Genetic Testing in Hyperlipidemia
Bilen, O., Pokharel, Y., & Ballantyne, C. M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.09.009 · Cited by 30
Diagnostic et traitement des hypercholestérolémies familiales (HF) chez l’adulte : recommandations de la Nouvelle société française d’athérosclérose (NSFA)
Farnier, M., Bruckert, É., Boileau, C., & Krempf, M. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.01.053 · Cited by 30
Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations
Watts, G. F., Juniper, A., van Bockxmeer, F., Ademi, Z., Liew, D., & O'Leary, P. C. (2012) · International Journal of Evidence-Based Healthcare · doi:10.1111/j.1744-1609.2012.00272.x · Cited by 29
Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia and Null Allele Low-Density Lipoprotein Receptor Mutations
Viladés, D., Leta, R., Carreras, F., Ollé, M. C., Barros-Membrilla, A. J., Perez, J. A. H., Pujadas, S., Alomar, X., Peral, M. F., & Pons‐Lladó, G. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.012 · Cited by 29
Lipoprotein(a) screening in young and middle-aged patients presenting with acute coronary syndrome
Jubran, A., Zetser, A., & Zafrir, B. (2018) · Cardiology Journal · doi:10.5603/cj.a2018.0106 · Cited by 29
Behavioural cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolaemia
Pérez‐Calahorra, S., Civeira, F., Guallar‐Castillón, P., Pintó, X., Banegas, J. R., Pedro‐Botet, J., Tembra, M. S., Mauri, M., Soler, C., Rodríguez‐Artalejo, F., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319896138 · Cited by 29
Self-citation
Predicting non-adherence in patients with familial hypercholesterolemia
Galema-Boers, J. M. H., Lenzen, M. J., van Domburg, R. T., van Lennep, J. E. R., Scheur, G. G. V. B.-V., Sijbrands, E. J. G., & Langendonk, J. G. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1640-3 · Cited by 30
Mutations in the LDL receptor gene in four Chinese homozygous familial hypercholesterolemia phenotype patients
Wang, L., Lin, J., Liu, S., Cao, S., Liu, J., Yong, Q., Yang, Y., Wu, B., Pan, X.-D., Du, L., et al. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.07.011 · Cited by 29
Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia
Langslet, G., & Ose, L. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.814851 · Cited by 29
Hepatotoxicity of Cardiovascular and Antidiabetic Drugs
Marzio, D. H., & Navarro, V. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00029-7 · Cited by 29
PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice
Leggiero, E., Astone, D., Cerullo, V., Lombardo, B., Mazzaccara, C., Labruna, G., Sacchetti, L., Salvatore, F., Croyle, M. A., & Pastore, L. (2013) · Gene Therapy · doi:10.1038/gt.2013.38 · Cited by 28
Preventing Early Cardiovascular Death in Patients With Familial Hypercholesterolemia
Repas, T. B., & Tanner, J. R. (2014) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2014.023 · Cited by 28
Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia
Vaca, G., Vázquez, A. C., Magaña, M. T., Ramírez‐Dueñas, M. D. L., Dávalos, I. P., Martínez, E. S., Marìn, B., & Carrillo, G. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.006 · Cited by 27
Polydopamine-assisted deposition of heparin for selective adsorption of low-density lipoprotein
Liu, Y., Qiu, W., Yang, H., Qian, Y., Huang, X., & Xu, Z. (2015) · RSC Advances · doi:10.1039/c4ra16700g · Cited by 26
Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box
Chan, D. C., & Watts, G. F. (2011) · Metabolism · doi:10.1016/j.metabol.2011.07.014 · Cited by 26
Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey
Schofield, J. D., Kwok, S., France, M. W., Capps, N. E., Eatough, R., Yadav, R., Ray, K. K., & Soran, H. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.009 · Cited by 25
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States
Spencer, S., Jones, L. K., Guzauskas, G. F., Hao, J., Williams, M. S., Peterson, J. F., & Veenstra, D. L. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.07.014 · Cited by 25
Serious drug-induced liver disease secondary to ezetimibe
Castellote, J., Ariza, J., Rota, R., Girbau, A., & Xiol, X. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5098 · Cited by 25
Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
Al-Ashwal, A. A., Alnouri, F., Sabbour, H. M., Almahfouz, A., Al-Sayed, N., Razzaghy‐Azar, M., Al-Allaf, F. A., Al-Waili, K., Banerjee, Y., Genest, J. J., et al. (2015) · Current Vascular Pharmacology · doi:10.2174/1570161113666150827125040 · Cited by 25
Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia
Skoumas, I., Masoura, C., Pitsavos, C. E., Tousoulis, D., Papadimitriou, L., Aznaouridis, K. A., Chrysohoou, C. A., Giotsas, N., Toutouza, M. G., Tentolouris, C. A., et al. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.005 · Cited by 25
Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Carroll, C., Tappenden, P., Rafia, R., Hamilton, J. A., Chambers, D., Clowes, M., Durrington, P. N., Qureshi, N., & Wierzbicki, A. S. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0492-6 · Cited by 24
Evaluation of the role of STAP1 in Familial Hypercholesterolemia
Danyel, M., Ott, C., Grenkowitz, T., Salewsky, B., Hicks, A. A., Fuchsberger, C., Steinhagen‐Thiessen, E., Bobbert, T., Kassner, U., & Demuth, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-48402-y · Cited by 24
Yellow Himalayan Raspberry (Rubus ellipticus Sm.): Ethnomedicinal, Nutraceutical, and Pharmacological Aspects
Lamichhane, A., Lamichhane, G., & Devkota, H. P. (2023) · Molecules · doi:10.3390/molecules28166071 · Cited by 27
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood
Langslet, G., Bogsrud, M. P., Halvorsen, I., Fjeldstad, H. E., Retterstøl, K., Veierød, M. B., & Ose, L. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.08.008 · Cited by 24
A New Model of Care for Familial Hypercholesterolaemia from Western Australia: Closing a Major Gap in Preventive Cardiology
Watts, G. F., BOCKXMEER, F. M. V., Bates, T. R., Burnett, J. R., Juniper, A., & O'Leary, P. C. (2010) · Heart Lung and Circulation · doi:10.1016/j.hlc.2010.02.002 · Cited by 23
A Salt Stimulus-Responsive Nanohydrogel for Controlled Fishing Low-Density Lipoprotein with Superior Adsorption Capacity
Cao, J.-F., Wang, X., Zhang, Y., Shu, Y., & Wang, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c21150 · Cited by 23
Cascade Screening in Familial Hypercholesterolemia: Advancing Forward
Santos, R. D., Frauches, T. S., & Chacra, A. P. M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.31237 · Cited by 23
Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia
Pereira, C., Miname, M. H., Makdisse, M. R. P., Filho, R. K., & Santos, R. D. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140097 · Cited by 23
Communicating Familial Hypercholesterolemia Genetic Information Within Families
Maxwell, S. J., Molster, C. M., Poke, S. J., & O'Leary, P. C. (2009) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2008.0138 · Cited by 23
Guidelines for the Diagnosis and Management of Familial Hypercholesterolaemia
SULLIVAN, D. R. (2007) · Heart Lung and Circulation · doi:10.1016/j.hlc.2006.10.019 · Cited by 23
Lipid-lowering response in subjects with the p.(Leu167del) mutation in the APOE gene
Bea, A. M., Lamíquiz-Moneo, I., Marco-Benedí, V., Mateo‐Gállego, R., Pérez‐Calahorra, S., Jarauta, E., Martín, C., Cenarro, A., & Civeira, F. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.01.024 · Cited by 24
Self-citation
Prise en charge des hypercholestérolémies de l'enfant
Girardet, J.-P. (2005) · Archives de Pédiatrie · doi:10.1016/j.arcped.2005.09.020 · Cited by 23
Premature Coronary Artery Disease and Familial Hypercholesterolemia: Need for Early Diagnosis and Cascade Screening in the Indian Population
Setia, N. W., Verma, I. C., Khan, B. V., & Arora, A. (2011) · Cardiology Research and Practice · doi:10.1155/2012/658526 · Cited by 22
A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries
Mundal, L. J., & Retterstøl, K. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000300 · Cited by 22
The value of physical signs in identifying patients with familial hypercholesterolemia in the era of genetic testing
Rallidis, L. S., Iordanidis, D., & Iliodromitis, E. K. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.07.005 · Cited by 22
The Efficacy of Colesevelam HCl in the Treatment of Heterozygous Familial Hypercholesterolemia in Pediatric and Adult Patients
Davidson, M. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.06.014 · Cited by 22
Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype
Sanin, V., Pfetsch, V., & Köenig, W. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0869-3 · Cited by 24
Cost-Effectiveness of Managing Familial Hypercholesterolemia Using Atorvastatin-Based Preventive Therapy
Rodrigo Alonso, K., de Bobadilla, J. F., Méndez, I., Lázaro, P., Mata, N., & Mata, P. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60139-5 · Cited by 22
Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
Sharma, P., Boyers, D., Boachie, C., Stewart, F., Miedzybrodzka, Z., Simpson, W., Kilonzo, M. M., McNamee, P., & Mowatt, G. (2012) · Health Technology Assessment · doi:10.3310/hta16170 · Cited by 21
Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio
Taranto, M. D. D., de Falco, R., Guardamagna, O., Massini, G., Giacobbe, C., Auricchio, R., Malamisura, B., Proto, M., Palma, D., Greco, L., et al. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1037 · Cited by 21
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease
Vikulova, D. N., Trinder, M., Mancini, G. B. J., Pimstone, S. N., & Brunham, L. R. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.08.012 · Cited by 21
The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease
Vogt, A., & Parhofer, K. G. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.779253 · Cited by 21
Heterozygous Familial Hypercholesterolaemic Patients have Increased Arterial Stiffness, as Determined using the Augmentation Index
Plana, N., Ferré, R., Merino, J., Aragonès, G., Girona, J., Heras, M., & Masana, L. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9795 · Cited by 21
Molecular diagnosis of familial hypercholesterolemia: an important tool for cardiovascular risk stratification.
Alves, A. C., Medeiros, A. M., Francisco, V., Gaspar, I. M., Rato, Q., & Bourbon, M. (2010) · PubMed · Cited by 21
Family History of Coronary Heart Disease: Evidence-Based Applications
Crouch, M. A., & Gramling, R. E. (2005) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2005.09.008 · Cited by 21
Familial hypercholesterolaemia: a look back, a look ahead
Burnett, J. R., Ravine, D., BOCKXMEER, F. M. V., & Watts, G. F. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06810.x · Cited by 20
Association Between the Presence of Carotid Artery Plaque and Cardiovascular Events in Patients With Genetic Hypercholesterolemia
Bea, A. M., Civeira, F., Jarauta, E., Lamíquiz-Moneo, I., Pérez‐Calahorra, S., Marco-Benedí, V., Cenarro, A., & Mateo‐Gállego, R. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.01.023 · Cited by 20
Self-citation
Current Treatment of Familial Hypercholesterolaemia
Lambert, C. T., Sandesara, P. B., Isiadinso, I., Góngora, M. C., Eapen, D. J., Bhatia, N. K., Baer, J., & Sperling, L. S. (2014) · European Cardiology Review · doi:10.15420/ecr.2014.9.2.76 · Cited by 20
Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia
Wang, X., Cai, G., Wang, Y., Liu, R., Xi, Z., Li, G., Wen, W., Wu, Y., Wang, C., Ji, Q., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1074-8 · Cited by 20
Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: Effects of simvastatin
Santos, R. D., Chacra, A. P. M., Morikawa, A. T., Vinagre, C. G. C., & Maranhão, R. C. (2005) · Lipids · doi:10.1007/s11745-005-1437-6 · Cited by 20
A genetic variant in the LDLRpromoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia
de Castro-Orós, I., Pérez-López, J., Mateo‐Gállego, R., Rebollar, S., Ledesma, M., León, M., Cofán, M., Casasnovas, J. A., Ros, E., Rodríguez-Rey, J. C., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-17 · Cited by 20
Self-citation
Serum Lipid Responses to Weight Loss Differ between Overweight Adults with Familial Hypercholesterolemia and Those with Familial Combined Hyperlipidemia
Mateo‐Gállego, R., Pérez‐Calahorra, S., Cofán, M., Baila-Rueda, L., Cenarro, A., Ros, E., Puzo, J., & Civeira, F. (2014) · Journal of Nutrition · doi:10.3945/jn.114.191775 · Cited by 19
Self-citation
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
Moriarty, P. M., Parhofer, K. G., Babirak, S. P., deGoma, E. M., Duell, P. B., Hohenstein, B., Ramlow, W., Simha, V., Steinhagen‐Thiessen, E., Thompson, P. D., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.02.003 · Cited by 19
Anionic glycosylated polysulfone membranes for the affinity adsorption of low-density lipoprotein via click reactions
Fang, F. Y., Zhu, X., Chen, C., Li, J., Chen, D., & Huang, X. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.050 · Cited by 19

Authors: Civeira, F.
Affiliations: Hospital Universitario Miguel Servet (ES)
Corresponding author: Civeira, Fernando
ORCID: Civeira, Fernando
Venue: Atherosclerosis
Publisher: Elsevier BV
Published: 2004-03
Volume: 173
Issue: 1
Pages: 55-68
ISSN: 0021-9150 (ISSN-L)
DOI: 10.1016/j.atherosclerosis.2003.11.010
OpenAlex: W2042489459
Cited by: 495
References: 125
Citations by year: 2026: 3 · 2025: 2 · 2024: 14 · 2023: 10 · 2022: 23 · 2021: 15 · 2020: 26 · 2019: 25 · 2018: 28 · 2017: 30 · 2016: 34 · 2015: 27 · 2014: 41 · 2013: 36 · 2012: 24
FWCI: 18.32
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Atherosclerosis (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: heterozygous familial hypercholesterolemia, LDL cholesterol, coronary artery disease, cardiovascular disease prevention, diagnosis, treatment, tendon xanthomas, lipoprotein metabolism
MeSH terms: Adult, Aged, Hypolipidemic Agents, Combined Modality Therapy, Diet, Female, Heterozygote, Humans, Hyperlipoproteinemia Type II, Life Style, Male, Middle Aged, Prognosis, Severity of Illness Index, Global Health, Survival Analysis, Age Distribution, Sex Distribution, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks